{
    "id": 714,
    "fullName": "FGFR3 K652E",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "FGFR3 K652E (corresponds to K649E in the canonical isoform) lies within the protein kinase domain of the Fgfr3 protein (UniProt.org). K652E was demonstrated to induce transformation of mouse fibroblasts, but had a lesser degree of signaling and phenotypic effect in immortalized normal human urothelial cells (PMID: 19749790) and therefore, is predicted to result in a gain of Fgfr3 protein function.",
            "references": [
                {
                    "id": 373,
                    "pubMedId": 19749790,
                    "title": "Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19749790"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2261,
        "geneSymbol": "FGFR3",
        "terms": [
            "FGFR3",
            "ACH",
            "CD333",
            "CEK2",
            "HSFGFR3EX",
            "JTK4"
        ]
    },
    "variant": "K652E",
    "createDate": "06/13/2014",
    "updateDate": "10/05/2018",
    "referenceTranscriptCoordinates": {
        "id": 116919,
        "transcript": "NM_001163213",
        "gDna": "chr4:g.1806162A>G",
        "cDna": "c.1954A>G",
        "protein": "p.K652E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1034,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, R3Mab inhibited ligand-dependent cell proliferation in cells expressing FGFR3 K652E in culture (PMID: 19381019).",
            "molecularProfile": {
                "id": 817,
                "profileName": "FGFR3 K652E"
            },
            "therapy": {
                "id": 1465,
                "therapyName": "R3Mab",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 742,
                    "pubMedId": 19381019,
                    "title": "Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19381019"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13801,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Derazantinib (ARQ 087) inhibited growth of bladder cancer cells harboring FGFR3 K652E in culture (PMID: 27627808).",
            "molecularProfile": {
                "id": 817,
                "profileName": "FGFR3 K652E"
            },
            "therapy": {
                "id": 2900,
                "therapyName": "Derazantinib",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11276,
                    "pubMedId": 27627808,
                    "title": "Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27627808"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 817,
            "profileName": "FGFR3 K652E",
            "profileTreatmentApproaches": [
                {
                    "id": 7520,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR3 K652E"
                },
                {
                    "id": 7521,
                    "name": "FGFR3 Inhibitor",
                    "profileName": "FGFR3 K652E"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 116919,
            "transcript": "NM_001163213",
            "gDna": "chr4:g.1806162A>G",
            "cDna": "c.1954A>G",
            "protein": "p.K652E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 116917,
            "transcript": "XM_006713871",
            "gDna": "chr4:g.1806162A>G",
            "cDna": "c.1954A>G",
            "protein": "p.K652E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 116918,
            "transcript": "XM_011513420",
            "gDna": "chr4:g.1806162A>G",
            "cDna": "c.1954A>G",
            "protein": "p.K652E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 116916,
            "transcript": "XM_006713870",
            "gDna": "chr4:g.1806159A>G",
            "cDna": "c.1954A>G",
            "protein": "p.K652E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}